NCT00295919 2023-04-07
N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
Children's Hospital Los Angeles
Phase 1 Completed
Children's Hospital Los Angeles
South Plains Oncology Consortium
South Plains Oncology Consortium